JPRN-UMIN000046671
Not yet recruiting
未知
Effectiveness for the shorting of hemostatic time using RDI on bleeding by biopsy forcep - RDI-hara study
Toho University Omori Medical Center Division of Gastroenterology and hepatology0 sites40 target enrollmentJanuary 19, 2022
Conditionsulcerlative colitis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- ulcerlative colitis
- Sponsor
- Toho University Omori Medical Center Division of Gastroenterology and hepatology
- Enrollment
- 40
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Not remission phase of ulcerlative colitis 2\. performed endoscopic hemostasis due to no spontaneous hemostasis 3\. takign biopsy from several locations of colon 4\. history of taking steroid and/or immunosuppresion medicine and/or biopharmarcy and/or G\-CAP 5\. no cessation of antithrombotic drugs 6\. hemodialysis 7\. no take an informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Evaluation of Haemostatic Efficacy, Tolerability and Safety of Kedrion Fibrin Sealant in patients undergoing major or minor Liver Surgery. Multicenter, Controlled, Open Label Randomised Phase II/III study. - KB048EUCTR2009-011603-23-ITKEDRIO
Completed
Not Applicable
Establishment of Hemostatic Protocol and Effectiveness of Alleviating Pain with TR band after Transradial Coronary CatheterizatioAngina PectorisJPRN-UMIN000023613St Luke's International Hospital400
Completed
Not Applicable
Evaluation of Hemostatics in coagulation inhibited human blood with viscoelastic testing (ROTEM)R58D68.9Haemorrhage, not elsewhere classifiedCoagulation defect, unspecifiedDRKS00015034Bundeswehrkrankenhaus UlmKlinik für Anästhesie und IntensivmedizinSektion Notfallmedizin40
Completed
Not Applicable
Clinical investigation into efficacy, haemodynamics and tolerability of simvastatin versus placebo in patients with pulmonary arterial hypertensioPulmonary hypertensionCirculatory SystemOther pulmonary heart diseasesISRCTN27178415niversity Hospital Giessen (Germany)40
Not yet recruiting
Not Applicable
Target Activated Clotting time for anticoagulation during cardiopulmonary bypassNL-OMON27592niversity Medical Center Utrecht1,536